Study highlights another reason to keep RA under control

The U.S. Federal Trade Commission (FTC) is investigating healthcare providers DaVita and Fresenius Medical Care over allegations that the companies have been illegally...

The World Health Organization has called for 'immediate and concerted action' to protect children from contaminated medicines after a spate of child deaths linked to cough syrups last year.

Close to 100 children in Indonesia have died from acute kidney injury (AKI) so far this year, a health ministry official said on Wednesday, as a team of experts investigates the spike in cases.

A structured moderate-intensity physical activity and strength/flexibility program slowed kidney function decline compared with health education, an analysis of a randomized clinical trial suggests.

A new model utilizing simple anthropometric measurements provided a viable alternative to bioimpedance for assessing body fat percentage in predialysis patients with chronic kidney disease.

Deficiency of the pancreatic progenitor cell differentiation and proliferation factor gene was identified as a risk factor for chronic kidney disease in preclinical studies, representing a potential therapy target.

Use of cystatin C for chronic kidney disease evaluation and sodium–glucose cotransporter-2 inhibitors as first-line therapy are among the changes put forth by KDIGO.

In a first renal outcome trial of its kind, the SGLT2 inhibitor showed favorable outcomes in the most advanced stages of CKD.

Intensive blood pressure control in patients with chronic kidney disease showed cardiovascular benefits in real-world settings similar to those observed in the SPRINT.

An intervention designed to better manage acute kidney injury in hospitalized patients through recommendations from a dedicated kidney action team did not meet the primary outcome.

Patients with ANCA-associated vasculitis receiving low glucocorticoid doses as per the PEXIVAS trial faced an increased risk for death, renal failure, progression, or relapse in this real-world study.

The risk for emergently treated hypocalcemia in individuals receiving denosumab peaked at 2 weeks after administration and returned to its baseline level by around 10 weeks.

Using an innovative analysis technique, researchers identified antinephrin autoantibodies as markers of difficult to diagnose kidney diseases.

Three international nephrology organizations call for World Health Organization recognition of CKD as a major noncommunicable mortality driver.

Clinicians should consider detailed testing of patients with cognitive complaints for accurate diagnosis and management.

A resting heart rate ≥ 80 beats/min increased the risk for mortality and cardiovascular events in Japanese patients with non–dialysis-dependent chronic kidney disease, a study showed.

Recipients of kidney transplants in high heat index settings show higher rates of adverse kidney outcomes than transplant recipients in cooler settings.

Lowering urate levels with urate-lowering therapy was not associated with an increased risk for severe or end-stage kidney disease in patients with gout and chronic kidney disease stage III.

Fifteen percent of Americans have chronic kidney disease, so why do only 10% know about it? Primary care clinicians can and should be doing more to identify patients.